Glucosio Monico

Glucosio Monico is a sterile solution for injection that contains glucose monohydrate as the active ingredient. It is supplied in an unspecified strength and is marketed in the European Union. The product is classified as a carbohydrate/osmotic agent and is prescribed for parenteral nutrition, fluid and electrolyte replacement, and the treatment of hypoglycemia.

Glucosio Monico is indicated for several clinical situations where rapid glucose supplementation or fluid expansion is required.

- Treatment of acute hypoglycemia in patients unable to take oral glucose. - Component of parenteral nutrition regimens for patients unable to receive enteral feeding. - Fluid and electrolyte replenishment during dehydration or postoperative care. - Supportive therapy in surgical or trauma patients to maintain extracellular volume. - Adjunct in metabolic disorders where glucose provision is needed.

Adverse reactions to Glucosio Monico may vary in frequency and severity.

Common: - Local irritation or pain at the injection site. - Hyperglycemia (elevated blood glucose levels). - Electrolyte imbalance, particularly sodium or potassium shifts. - Fluid overload leading to peripheral edema. - Nausea or mild gastrointestinal discomfort.

Serious: - Severe hyperglycemia with risk of ketoacidosis. - Pulmonary edema from rapid volume expansion. - Anaphylactic or severe hypersensitivity reactions. - Metabolic acidosis. - Cardiac arrhythmias secondary to electrolyte disturbances.

When prescribing Glucosio Monico, clinicians should consider several safety factors.

- Assess blood glucose levels before and during therapy to avoid hyperglycemia. - Monitor fluid balance and signs of overload, especially in patients with cardiac or renal impairment. - Evaluate electrolyte status regularly, adjusting concomitant electrolyte therapy as needed. - Use caution in patients with diabetes mellitus or insulin resistance. - Consider pregnancy status; data are limited, so risk‑benefit assessment is required. - Ensure proper aseptic technique to prevent infection at the injection site.

Glucosio Monico may interact with other agents that affect glucose or fluid balance.

Avoid: - Concurrent use of high‑dose insulin without close glucose monitoring. - Co‑administration with other hyperosmolar solutions that may exacerbate fluid overload. - Simultaneous use of medications that cause hypokalemia, increasing risk of electrolyte imbalance.

Use with caution: - Diabetic oral hypoglycemic agents (e.g., sulfonylureas, metformin). - Loop or thiazide diuretics, which may alter electrolyte status. - Corticosteroids, which can raise blood glucose levels. - Vasopressors, as rapid volume expansion may affect hemodynamics.